South China Journal of Preventive Medicine ›› 2022, Vol. 48 ›› Issue (10): 1165-1169.doi: 10.12183/j.scjpm.2022.1165
• Consensus, Standards and Guidelines • Next Articles
Received:2022-01-06
Online:2022-10-20
Published:2022-12-13
CLC Number:
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
| [1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志,2021,37(4):311-398. [2] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-66. [3] Schnurr TM, Jakupovi H, Carrasquilla GD, et al.Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: A case-cohort study[J].Diabetologia,2020,63(9995):1324-1332 . [4] 冯静,刘欢,许丹,等. 肥胖2型糖尿病患者合并血脂异常和高血压情况分析[J].中国全科医学, 2019,22(S1):64-66. [5] 周丽诺, 俞茂华, 李红,等. 肥胖和非肥胖2型糖尿病患者的临床特点及影响其心功能的多因素探讨[J]. 中国糖尿病杂志, 2002(3):135-138. [6] 刘星, 刘秀荣, 杨春伟,等. 腹型肥胖对糖尿病人群新发高尿酸血症影响的研究[J]. 中国糖尿病杂志, 2014, 22(11):970-973. [7] 夏阳阳, 顾天伟, 蒋春明, 等. 2型糖尿病患者发生慢性肾脏病的危险因素及与肥胖的相关性研究[J]. 中华糖尿病杂志, 2022, 14(2):140-146. [8] Yi M, Chen RP, Yang R, et al.Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China[J]. Diabet Med, 2017,34(4):505-513. [9] 母义明,杨文英, 朱大龙,等.磺脲类药物临床应用专家共识(2016年版)[J]. 药品评价, 2017, 14(1):5-12,54. [10] Lean ME, Leslie WS, Barnes AC, et al.Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomized trial[J]. Lancet,2018,391(10120):541-551. [11] Zhang F, Luo W, Shi Y, et al.Should we standardize the 1,700-year-old fecal microbiota transplantation?[J]. Am J Gastroenterol, 2012, 107(11):1755-1755. [12] Vrieze A, Nood EV, Fuentes S, et al.Duodenal infusion of donor feces for recurrent clostridium difficile[J]. N Engl J Med, 2013.368(5):407-415. [13] 中华医学会. 肥胖症基层诊疗指(2019)[J]. 中华全科医师杂志,2020,19(2):102-107. [14] 中华医学会内分泌学分会,中华中医药学会糖尿病分会,中国医师协会外科医师分会,肥胖和糖尿病外科医师委员会,中国研究型医院学会糖尿病与肥胖外科专业委员会.基于临床的肥胖症多学科诊疗共识(2021年版).中华消化外科杂志. 2021,20(11):1137-1152. [15] Le Chatelier E, Nielsen T, Qin J, et al.Richness of human gut microbiome correlates with metabolic markers[J]. Nature, 2013, 500(7464):541-546. [16] Ridaura VK, Faith JJ, Rey FE, et al.Gut microbiota from twins discordant for obesity modulate metabolism in mice[J]. Science, 2013, 341(6150):1241214. [17] Kootte RS, Vrieze A, Holleman F, et al.The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus[J].Diabetes Obes Metab,2012,14(2) :112-120. [18] Vrieze A, Nood V, Holleman F, et al.Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J].Gastroenterology,2012,143(4):913-916. [19] Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al.High-fat diet determines the composition of the murine gut microbiome independently of obesity[J]. Gastroenterology, 2009, 137(5):1716-1724. [20] David LA, Maurice CF, Carmody RN, et al.Diet rapidly and reproducibly alters the human gut microbiome[J]. Nature, 505(7484):559-563. [21] Singh R, Nieuwdorp M, Berge IT, et al.The potential beneficial role of faecal microbiota transplantation in diseases other than clostridium difficile infection[J]. Clin Microbiol Infect, 2015, 20(11):1119-1125. [22] Mocanu V, Zhang Z, Deehan EC, et al.Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: A randomized double-blind, placebo-controlled phase 2 trial[J]. Nature Medicine,2021,27(7):1272-1279. [23] Mullish BH, Nabil QM, Segal JP, et al.The use of faecal microbiota transplant as treatment for recurrent or refractory infection and other potential indications: Joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines[J]. Gut, 2018,67(11):1920-1941. [24] Cammarota G, Ianiro G, Kelly CR, et al.International consensus conference on stool banking for faecal microbiota transplantation in clinical practice[J]. Gut, 2019, 68(12):2111-2121. [25] Haifer C, Kelly CR, Paramsothy S, et al.Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice[J]. Gut, 2020, 69(5):801-810. [26] Zhang S, Wu P, Tian Y, et al.Gut microbiota serves a predictable outcome of short-term low-carbohydrate diet (LCD) intervention for patients with obesity[J]. Microbiol Spectr,2021,9(2):e0022321. [27] 张雪莹, 陈启仪, 李宁, 等. 菌群移植适应证的选择和临床应用策略[J]. 中华胃肠外科杂志,2020,23(5): 509-515. [28] Jobin, Christian.Precision medicine using microbiota[J]. Science, 2018,359(6371):32-34. [29] Mc Donald LC, Gerding DN, Johnson S, et al.Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)[J].Clin Infect Dis, 2018, 66(7):987-994. [30] 李宁,田宏亮,陈启仪,等.菌群移植治疗肠道疾病2 010例疗效分析[J].中华胃肠外科杂志,2019,22(9):861-868. [31] 张发明, 刘亚飞. 洗涤菌群移植途径选择的证据与决策[J]. 中华胃肠外科杂志, 2020, 23(Z1):45-47. [32] Kim HN, Yun YJ, Ryu S, et al.Correlation between gut microbiota and personality in adults: A cross-sectional study[J]. Brain Behav Immun, 2018, 69(12):374-385. [33] Lai CY, Sung J, Cheng F, et al.Systematic review with meta-analysis: Review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation[J].Aliment Pharmacol Ther, 2019, 49(4):354-363. [34] Ding C, Fan W, Gu L, et al.Outcomes and prognostic factors of fecal microbiota transplantation in patients with slow transit constipation: results from a prospective study with long-term follow-up[J]. Gastroenterology Report, 2018, 6(2):101-107. [35] 张薛磊, 田宏亮, 马春联, 等. 阶段性菌群移植治疗顽固性便秘疗效观察[J].中华胃肠外科杂志,2017, 20(12):1355-1359. [36] 中华医学会肠外肠内营养学分会, 中国国际医疗保健促进交流会加速康复外科分会, 中国微生态治疗创新联盟,等. 菌群移植标准化方法学的建立与临床应用中国专家共识[J]. 中华胃肠外科杂志, 2020, 23(Z1):5-13. [37] 中国超重肥胖医学营养治疗专家共识编写委员会. 中国超重/肥胖医学营养治疗专家共识(2016年版)[J]. 中华糖尿病杂志, 2016,8(9):525-540. [38] Gong Q, Zhang P, Wang J, et al.Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study[J]. Lancet Diabetes Endocrinol,2019,7(6):452-461. [39] 中华预防医学会微生态学分会.中国微生态调节剂临床应用专家共识(2020版)[J].中华临床感染病杂志, 2020, 13(4):241-256. [40] 中华预防医学会微生态学分会.中国消化道微生态调节剂临床应用专家共识(2016版)[J].中华消化杂志, 2016, 36(12):793-804. [41] Ruan Y, Sun J, He J, et al.Effect of probiotics on glycemic control: A systematic review and meta-analysis of randomized, controlled trials[J].PLoS One, 2015,10(7):e132121. [42] Reynolds A, Mann J, Cummings J, et al.Carbohydrate quality and human health: A series of systematic reviews and meta-analyses[J]. Lancet, 2019, 393(10170):434-445. [43] Mocanu V, Zhang Z, Deehan EC, et al.Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: A randomized double-blind, placebo-controlled phase 2 trial[J]. Nat Med,2021, 27(7): 1272-1279. |
| [1] | . [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1294-1297. |
| [2] | . [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1205-1208. |
| [3] | YAN Yongfeng, XU Yuanyou, WANG Jun, CHEN Yongsheng, ZHANG Yonghui, DING Lulu, CHEN Jianguo, FAN Jian, ZHU Jian. Trend analysis of brain tumor survival rate in Qidong City, Jiangsu Province, 1972 - 2016 [J]. South China Journal of Preventive Medicine, 2023, 49(8): 960-964. |
| [4] | FAN Hailong, NIU Yanbin, GUO Zhenshan, AN Qianjiang, WANG Xiumei. Association between visceral adiposity index and blood glucose variation in Chinese middle-aged and elderly prediabetic population： a cohort study [J]. South China Journal of Preventive Medicine, 2023, 49(7): 803-807. |
| [5] | OUYANG Xiaoyao, LI Zhansheng, SUN Shuyue, JING Qi, SHANG Qianqian, LI Wenjun, JI Lihong, ZHANG Jianhua. Status and influencing factors of mild cognitive impairment among elderly patients with type 2 diabetes mellitus in community based on health ecological aspect [J]. South China Journal of Preventive Medicine, 2023, 49(7): 828-833. |
| [6] | . [J]. South China Journal of Preventive Medicine, 2023, 49(7): 891-895. |
| [7] | . [J]. South China Journal of Preventive Medicine, 2023, 49(7): 904-907. |
| [8] | ZHANG Xiaoliang, MA Qiu, ZHANG Li, DENG Yuwei, PENG Hui. Investigation and analysis of the incidence and risk factors of gallstones in Dayi County, Chengdu City [J]. South China Journal of Preventive Medicine, 2023, 49(6): 686-689. |
| [9] | LIU Mengyu, HU Mingjun, HE Jialiu, ZHU Jinliang, HUANG Fen, LV Jianjian, QIN Qirong. Prevalence and influencing factors of pulmonary nodules among community residents with high risk of lung cancer in Maanshan City [J]. South China Journal of Preventive Medicine, 2023, 49(6): 729-734. |
| [10] | . [J]. South China Journal of Preventive Medicine, 2023, 49(6): 755-758. |
| [11] | . [J]. South China Journal of Preventive Medicine, 2023, 49(6): 774-777. |
| [12] | . [J]. South China Journal of Preventive Medicine, 2023, 49(6): 788-792. |
| [13] | CHEN Fang, WU Kai, YANG Yan, XU Mingxing. Prevalence of thyroid nodules in school-age children in Wuhan and its correlation with iodine nutrition [J]. South China Journal of Preventive Medicine, 2023, 49(5): 558-562. |
| [14] | . [J]. South China Journal of Preventive Medicine, 2023, 49(4): 466-468. |
| [15] | . [J]. South China Journal of Preventive Medicine, 2023, 49(4): 485-488. |
|
||
